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Aortic stenosis patients with severe LV dysfunction and low cardiac output present with
relatively low transvalvular gradients. It is difficult to distinguish them from aortic scle-
rosis and LV dysfunction with low cardiac output. The former condition is severe AS with
LV dysfunction and latter is primarily a contractile dysfunction. Dobutamine stress echo-
cardiogram is key to diagnosis.
AS with LV dysfunction associated with preserved contractile reserve benefit from valve
replacement and those without contractile reserve needs critical evaluation on a case to
case basis. Patients of AS with LV dysfunction with associated coronary artery disease need
coronary angiograms to decide regarding need for valve replacement with bypass surgery.
A subset of AS patients have low flow, low mean gradients with preserved ejection fraction
in whom one must evaluate global hemodynamic load to assess ventriculo-arterial
impedence.
In this review an approach to the clinical pathways for assessment of low flow, low
gradient aortic stenosis has been discussed.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
There are four hemodynamic variants of severe valvular aortic
stenosis (AS) 1) Asymptomatic severe AS with preserved left
ventricular (LV) function 2) Symptomatic severe AS with
either preserved LV function or LV dysfunction 3) Lowflow (LF)
low gradient (LG) aortic stenosis with severe LV dysfunction 4)
LF, LG, AS with preserved LV function. The aim of the present
review is to discuss the last two variants.Sathyamurthy).
ciety of India. All rightsIn this article an attempt has beenmade to simplify clinical
pathways of patients with AS presenting with low stroke
volume (SV), consequently low flow and low gradients across
aortic valve. Low flow, low gradients occur in the setting of LV
systolic dysfunction with low ejection fraction (EF) or small
ventricular volumes, consequent to severe LVH with pre-
served EF. These patients can be classified into 5 categories
(AeE) as shown in flowchart (Fig. 1).
The new entity of LF LG AS associated with preserved LVEF
formsGroup E (Fig. 1-E). Patientswith LF LGASwith low EF canreserved.
Fig. 1 e Flowchart. EF-Ejection fraction, SV-Stroke Volume, AVA-Aortic Valve area, CAD-Coronary Artery Disease.
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disease (CAD) e the Group D (Fig. 1-D) and those without CAD.
Patients without associated CAD can be further divided into
pseudo severe AS e Group C (Fig. 1-C) or true AS by Dobut-
amine stress echocardiography (DSE). Patients with true AS
can be further subdivided into those with preserved contrac-
tile reserve (CR) e Group A (Fig. 1-A) and those without CR e
Group B (Fig. 1-B).
These pathways help us evaluate whether it is true AS or
pseudo severe AS and also useful for assessment of reversible
causes ofmyocardial dysfunction like associated CADneeding
aortic valve replacement (AVR) with additional coronary ar-
tery bypass graft (CABG) surgery, prediction of perioperative
mortality and long term survival based on presence or
absence of contractile reserve.2. LF LG AS with severe LV dysfunction
(Group A & B in Fig. 1)
American College of Cardiology (ACC)/American Heart Asso-
ciation (AHA) guidelines1 for diagnosis of severe AS is shown
in Table 1. LF LG AS is characterized by combination of severe
aortic valve stenosis (calculated aortic valve area (AVA)<1 cm2
or 0.6 cm2/m2), low transvalvular gradient (mean
gradient<40mmHg) and low flow (stroke volume< 35ml/m2).
with this hemodynamic presentation it is difficult to distin-
guish true aortic valve stenosis where the primary culprit is
severe aortic valve disease and LV dysfunction from pseudo
severe AS where primary problem is myocardial dysfunction
(due to other secondary causes like severe multivessel CAD orTable 1 e Guideline criteria for severe aortic STENOSIS1.
ACC/AHA
Aortic valve area (AVA) <1.0 cm2, <0.6 cm2/m2 of b
Aortic mean pressure gradient (dpm) >40 mm Hg
Maximum aortic jet velocity >4 m/smyocardial disease) in whom aortic valve disease severity is
over estimated due to incomplete opening of rigid aortic valve
leaflets, as a consequence of decreased force of opening by
dysfunctional myocardium.
Differentiation of true severe AS from pseudo severe AS is
usually done by increasing flow across the stenotic aortic
valve by pharmacologic means by infusing dobutamine.
Effective orifice area (EOA) is the smallest cross sectional area
of the aortic Jet (area of the vena contracta) measured by
doppler.2,3 The EOA does not change in true AS even though
gradient may increase whereas in pseudo severe AS the
calculated EOA increases with no significant change in
gradient. Various quantitative criteria like peak stress EOA
<1.0 cm2, gradient >30 mmHg and absolute increase in EOA
<0.3 cm2 are sufficient for diagnosing true AS. However it
should be remembered that magnitude of flow augmented by
dobutamine is highly variable in individual patients and de-
pends upon multiple factors like contractile reserve, chrono-
tropic response, drugs like betablockers.
To overcome this variability of flow response in individual
patients, a new parameter, projected EOA (EOAproj) at normal
transvalvular flow rate of 250 ml/s has been suggested. The
EOA proj is calculated by using transvalvular flow at each
stage of DSE, valve compliance which is derived as slope of
regression line fitted to the EOA versus flow (Q) plot. The
diagnostic significance of EOA proj is superior to other echo
indices, as evidenced by themulticenter TOPAS study4 (true or
pseudo severe aortic stenosis study) of low flow AS.
The effect on SVwith dobutamine infusion helps indirectly
to assess the contractile reserve in patients with true AS.
When the SV increases by more than 20%, it confirmsESC
ody surface area <1.0 cm2, <0.6 cm2/m2 of body surface area
50 mm Hg
Table 2 e True vs pseudo aortic-stenosis.
True AS Pseudo AS
Rest Dobutamine Rest Dobutamine
CO L/min 3.5 5.0 3.5 5.0
Gradient mm Hg 25 40 25 25
AVA cm2 0.7 0.8 0.7 1.0
Abbreviation: CO, Cardiac output.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 6 7 2e6 7 7674preserved CR. These patients with preserved CR constitute
group A and those without CR constitute group B (Fig. 1).
Group A patients with preserved CR fare better with AVR
than those in Group B.5e8 An operative mortality of 10% in
group A and 30% in group B was reported by Monin et al6 with
better long term survival in group A. There was significant
improvement in symptoms and LV function following AVR in
group A as reported by the same investigators.7
In a well selected patient population with AVA 0.7 sq cm
and mean gradient 30 mm Hg, 4 year survival was <15% if
not operated as against 78% after AVR.9 Six year survival after
AVRwas 75% in patients with preserved CR as against survival
of 35% at 2 years in those without CR in a series of 136 patients
with EOA 1 sq cm, mean gradient 40 mm across AV re-
ported by Monin et al6
Without AVR however, the outcomes were extremely poor
in those without CR (Group B) managed conservatively with 2
year survival of only 15%.Thoughoperativemortality is high in
this subset of patients, 90% of those who survive perioperative
period show functional improvement and in 60% of them
improvement in LVEFupto 10%wasobserved inone series.7An
absence of CR should not be considered an absolute contrain-
dication for AVR and case by case evaluation of LF LG AS
without CR should be stressed upon as recommended by
Current European Society of Cardiology (ESC) guidelines.3. Pseudo severe AS (Group C in Fig. 1)
Pseudo severe AS is defined as AVA 1.2 sq. cm with mean
transaortic gradient 30 mm Hg at peak dobutamine infu-
sion.9,10 An example of a patient's response to inotropic
stimulation is shown in Table 2. In these cases LV dysfunction
is due to myocardial fibrosis or intrinsic myocardial disease in
the absence of any significant CAD. In these cases increase in
cardiac output causes much greater increase in flow than
gradient, resulting in large increase in AVA. Only 15% of cases
of LF LG AS belonged to Pseudo severe AS group as shown in
the Pooled data from 5 reported series6,9,11e13 (Table 3). The
documented mortality was 48e57% at 20 months follow up14
in these patients. Emilie et al15 compared AVR versus con-
servative management in 305 patients of LF LG AS (Table 4)
and concluded that in patients with pseudo severe AS, five
year survival with conservative management was better than
true AS. Caution should be exercised as DSE sometimes may
not distinguish Pseudo severe AS (Group C) from true AS
without CR (Group B). Patients with pseudo severe AS, LV
dysfunction is mainly due to intrinsic myocardial disease and
they do not benefit from AVR.84. LF LG AS associated with CAD (Group D in
Fig. 1)
In these cases severe AS is associated with coronary artery
diameter stenosis 50% in one or more coronaries contrib-
uting to LV dysfunction. Majority of patients in this subgroup
have comorbidities like diabetes, hypertension, dyslipidemia,
smoking or prior history of acute coronary syndrome. Echo-
cardiography reveals regional wall motion abnormalities,without any significant LV wall thinning. Position Emission
Tomography scans may be needed to assess the viability in
large akinetic areas. Surgical management with AVR plus
CABG offers good long term survival and improvement in LV
function if significant areas of viable myocardium and good
target vessels for revascularization are present though with a
high perioperative risk.
DSE is preferably avoided in this subset of patients with
CAD as dobutamine can precipitate angina, arrhythmias and
produce inconclusive results. In a large series of 217 consec-
utive patients reported by Frank Levy,16 DSE was done only in
38% of cases.
It is ideal to do invasive coronary angiography to detect and
assess severity of CAD in these patients. As ostial left main or
right coronary ostial stenosis can be missed due to densely
calcific aortic valves, it is preferable to avoidmulti detector CT
coronary angiography in these cases.
Overall 5 year survival was less in patients with associated
CAD compared to those without CAD as reported by Con-
nolley17 et al in a series of 52 patients. Another study by Frank
levy16 in 217 consecutive patients found that 5 year survival
was 37% in those with associated multivessel CAD and 55%
without multivessel CAD. Surgical treatment with AVR plus
CABG improved LVEF significantly with Perioperative mortal-
ity of 16% in their study.16
Some of the predictors of high surgical risk are higher Euro
scores,18 very low mean gradients, low LVEF, preoperative
atrial fibrillation, preoperative functional class and cardio
pulmonary bypass time. Perioperative mortality of 25% was
observed in patients with Euro score >10 as against 12% for
those with Euro score <1016. Improvement in functional class
by more than one NYHA class post operatively was noted in
88% of patients in the series reported by connolly et al5 and
76% in the series by Levy et al165. LF LG severe AS with preserved LV
function (Group E in Fig. 1)
Normal LVEF does not mean normal SV or normal systolic
function. Ejection fraction is usually calculated by simpson's
equation and is applicable when LV shape is elliptical. But in
severe AS there is concentric hypertrophy of LV with >50%
increase in relative wall thickness, a phenomenon known as
increased concentric remodeling (ICR). This ICR alters LV ge-
ometry and shape resulting in decreased LV filling and low SV
secondary to impaired diastolic function and decreased LV
end diastolic volume. When SV is low it results in low flow
situation leading to low mean gradients across aortic valve.19
Table 3 e Low flow low gradient AS-DSE.
Reference Incidence Stress method Follow up Mortality
deFilipi et al11 (1995) 5/18 (28%) Echo 12 20%
Schwammenthal et al12 (2001) 8/24 (30%) Echo 11 25%
Nishimura et al9 (2002) 7/32 (22%) Cath 32 57e100%
Monin et al6 (2003) 7/136 (5%) Echo 19 50%
Zuppiroli et al13 (2003) 10/48 (25%) Echo 24 70%
Pooled 37/258 (15%) e 20 48e57%
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 6 7 2e6 7 7 675What is normal EF with normal LV geometrymay be abnormal
for altered geometry due to concentric LV remodeling.
Inaccurate measurements of LV outflow tract (LVOT)
diameter can alter the calculation of SV and AVA. Under-
estimation of LVOT area can occur if the shape of LVOT is
eccentric to the aortic annulus and inconsistent measure-
ment of the severity of AS can be noted in about 30% of
cases.20 This inconsistency in the measurement of AVA by
transthoracic echocardiogram can be offset by using
planimetry with transoesophageal echocardiography or
Magnetic Resonance Imaging but at an added cost to the
patient.
Tissue Doppler imaging clearly demonstrates impaired
long axis shortening and changes in LV geometry in severe AS
with reduced contractility. LVEF may remain normal in these
cases by use of preload reserve. One third of patients with
asymptomatic severe AS and preserved LVEF were found to
have an impaired systolic function in the SEAS substudy.21 A
condition similar to LF LG AS was seen in these patients with
low SV and transaortic gradients. The major concern in these
cases is that underestimation of AVA can lead to underutili-
zation of valve replacement.22
Hachicha22 et al described ventriculo-arterial impedence
(Zva), an index of global hemodynamic load and related this to
the onset of symptoms and adverse events.Table 4 e Management according to DSE testing.VentriculoArterial impendenceðZvaÞ¼ systolic arterial pressureþmean net transaortic gradient
Stroke volume=BSA2
Height 2.04 can be substituted instead of BSA if SV is
indexed to height in this formula. A value of Zva 4.5 mmHg/
ml m2 may be useful to identify patients who are at risk of
deterioration of myocardial function as per previously re-
ported studies.21,23
Normal LVEF does not mean normal SV. Hachicha etal22
showed that one third of patients with severe AS had
reduced SV Index (SV/BSA <35ml/m2) despite preserved LVEF.
This results in low flow situation which in turn results in low
transvalvular gradients. In their study of 512 consecutive pa-
tients with echocardiographically determined low gradient
severe AS (AVA 0.6 cm2/m2) and LVEF50%, Hachicha etal22
found normal flow (NF) having SV index 35 ml in 65% of
cases and paradoxically low flow (PLF) having SV Index35ml
in 35% of cases. During 5 year follow up, patients with PLF had
a reduced survival compared to those with NF.
Guidelines24,25 regarding diagnostic and therapeutic rec-
ommendations for LF LG AS is shown in Table 5. Further
prospective studies are needed to determine the prognosis
and most appropriate timing of AVR in these asymptomatic
paradoxically LF LG AS patients with preserved LV function.
Table 5 e Guidelines for the diagnosis and management of LF LG AS with LV dysfunction.
Class of recommendation Level of evidence Reference
Dobutamine stress echocardiography for evaluation IIa B 24
cardiac catheterization for hemodynamic measurements with
dobutamine infusion
IIa C 24
AVR should be considered in symptomatic patients with low flow,
low gradient (<40 mmHg)AS with normal EF only after careful
confirmation of severe AS
IIa C 25
AVR should be considered in symptomatic patients with severe
AS, low flow, low gradient with reduced EF and evidence of
flow reserve
IIa C 25
AVR may be considered in symptomatic patients with severe
AS, low flow, low gradient and LV dysfunction without flow
reserve
IIb C 25
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Classical LF LGAS isdiagnosedwhenAVA0.6 sq cm/m2,mean
gradient 30 mm Hg and LVEF 35%. It intrigues cardiologists
and poses challenge in assessment of severity and appropriate
management. They comprise 10% of all patients of AS. DSE is
the key to proper diagnosis. An increased flow in the presence
of constant AVA with dobutamine infusion indicates presence
of true AS. Contractile reserve is considered present in these
cases if SV increases by 20%.The operative mortality is higher
with absent CR at 30% compared to 10% when CR is preserved.
AVR is associatedwith improved survival compared tomedical
treatment even in those with absent CR in some patients.
Proper evaluation and case by case decision is an absolute
requirement in these cases. Patients with pseudo severe AS
need conservative management. If there are large areas of
viablemyocardiumwith gooddistal target vessels in thosewith
associatedCADseemtobenefit fromAVRplusCABGsurgery. LF
LG ASwith preserved LV function is a new entity and one third
of themmay need AVR even if they are asymptomatic. Diligent
evaluation to plan individually tailored therapy is the key to
success in the management of LF LG AS.Conflicts of interest
All authors have none to declare.
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